BRI-6906

N/A

Report date: 2025/02/05 13:46:29

Base Information

Drug NameBRI-6906
Drug Alias NameBRI-6906
ClassificationSmall molecules > PeptidomimeticBiologics > Protein drugs > Toxin
Mechanisms of ActionVoltage-gated calcium channel blockersPotassium channel blockers
TargetsVoltage-gated calcium channelVoltage-gated potassium channel subunit Kv1.3Potassium channel
Therapy Area/IndicationsPainGraft vs Host DiseaseAutoimmune Diseases +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustralia and New Zealand
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesBiomolecular Research Institute
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBiomolecular Research Institute
Active IndicationsN/A
Inactive IndicationsPainGraft vs Host DiseaseAutoimmune Diseases +[5] 

Other Information

ATC CodeN/A
Related LinksN/A